| abstract |
The present invention relates to pharmaceutically acceptable salts of the compound of formula (I) or solvates of said salt in which the compound of formula (I) is as the (R)-enantiomer, the (S)-enantiomer or the racemate, a process for their preparation, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy. |